MOF, Alm.del - 2016-17 - Bilag 141: Henvendelse af 1/12-16 fra RE-N Technology Group om MRSA-løsning for svinestalde

Miljø- og Fødevareudvalget 2016-17
MOF Alm.del Bilag 141
Offentligt

Confidential

Zitta®StableFlush

MRSA Reduction

Subject to change, September 2016

Dansk OTC Finans A/S

Tingskiftevej 5

2900 Hellerup

Denmark

Partner Morten Svebølle

Direct +45 52404842

[email protected]

Re-N Technology ApS

Aaholmvej 6

DK-4320 Lejre

Denmark

CEO Jens Tradsborg

Direct +45 20200540

[email protected]

MOF, Alm.del - 2016-17 - Bilag 141: Henvendelse af 1/12-16 fra RE-N Technology Group om MRSA-løsning for svinestalde

Disclaimer

This Information Memorandum is strictly confidential and may not be copied, published, distributed or transmitted in whole or in part, of any medium or in any

form for any purpose. The Company and its advisers do not intend or assume any obligation to update information contained in this Information Memorandum,

and the information is subject to change without notice. There can be no guarantee, expressed or implied, as to the accuracy or completeness of this

Information Memorandum and the information it contains and investment decision should not be taken based on this information alone. No responsibility can be

made for any loss, howsoever arising, directly or indirectly, from this Information Memorandum and its contents.

This Information Memorandum has been prepared in order only to provide information and is not an offer or invitation to buy or sell any securities, nor shall all or

portions of this Information Memorandum form the basis of, or be relied on in connection with any investment decision with respect to any securities. This

Information Memorandum contains statements about future expectations are based on management's perception as well as management's assumptions and

information currently available to management, and these statements may constitute forward-looking statements. These forward-looking statements (other than

statements of historical fact) regarding the Company's future operating results, financial condition, cash flows, business strategy, plans are subject to known and

unknown risks, uncertainties and other important factors that could cause the Company’s actual results, performance or achievements or industry results to be

materially different from any future results, developments, or achievements expressed or implied by such forward-looking statements.

The distribution of this Information Memorandum in certain jurisdictions may be restricted by law and / or subject to restrictions, and the Information

Memorandum may not be used for or in connection with an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not authorized or

to any person to whom it is unlawful to make such offer or solicitation. This Information Memorandum is not an offer or solicitation to buy securities in any

jurisdiction in which such offer or solicitation is unlawful. The Company requires persons who come into possession of the Information Memorandum, to inform

themselves of and observe any such restrictions, including any tax and currency restrictions that may be relevant in connection with the Offering. Investors

agree to the foregoing by accepting delivery of this Information Memorandum, and accept themselves also to be responsible for their own assessment of the

Company's market and develop their own analysis and make their own assessments of the Company's potential future business performance.

MOF, Alm.del - 2016-17 - Bilag 141: Henvendelse af 1/12-16 fra RE-N Technology Group om MRSA-løsning for svinestalde

Technology to improve stable air quality and airborne disseises

Enabling Stables to Reduce Vapours

The new technology solution

The Company



Re-N Technology (Re-N) is a Research and

development company focusing on reducing

greenhouse gasses such as CO

O and

Developed the

Zitta®StableFlush

technology

concept based on preventing ammonia

vapours from the stable means less airborne

diseases, less antibiotics and higher

production rate.



The key to the new solution is based on

flushing recycled none-nitrogen liquid manure

through the stable pits in an efficient manner.

Key advantages



€0.02/ kg slaughter

pig

Low energy use

High efficiency

Environmental

friendly



Full service contract

available

Compact

Easy financial solution



The new technology and products are

combined branded as

Zitta®StableFlush

consisting of

Zitta®Systems, Ultralight

and

Zitta®Fertilizer.

Zitta®StableFlush

is an add-on product to

existing stables

Enabling stables to reduce Ammonia Vapours

towards zero and thus omit one distribution

channel for MRSA.

No chemicals in

stables

No waste products

No dust or smell



Zitta®StableFlush

capture and recycle the

nitrogen from the manure and converts it to a pure

non-organic fertilizer as a commercial product

Current solution

New solution generating Non-organic Fertilizer from Manure without Vapours

None-Nitrogen Liquid

Bacteria / Virus

Free

Liquid

Liquid Fraction

Vapour

Zitta®Systems

Separator

Zitta®Fertilizer

Manure Flush

Fiber Fraction

Manure Ring

MOF, Alm.del - 2016-17 - Bilag 141: Henvendelse af 1/12-16 fra RE-N Technology Group om MRSA-løsning for svinestalde

RE-N Technology & Business Concept

The Company



Established in 2008 with the sole purpose to

develop and patent new technologies and

products to reduce greenhouse gases

Re-N also own, manage and operate

Zitta®Biogas plants based on proprietary

technology/products



R&D is based in Sweden

Production facility in Denmark



The Netherland based subsidiary started the

Company’s portfolio of 9 large scale

Zitta®Biogas plants

Re-N currently operate one Zitta®Biogas plant

with plans of constructing a second 400,000

ton/year plant

The Company has long-term relations to a

number of consultants and networks



Office in California

Subsidiary in the Netherlands



Patented technologies and products



Deloitte (WW)

Danish Embassy



Wageningen

University (NE)

Stanford (US)

Dansk OTC (DK)

Zitta®StableFlush

Zitta®Fertilizer

Zitta®Biogas



AWA Patent lawyers



Danders&More (DK)



Business concept & strategy



Pain



MRSA and other bacteria are transmitted through the air in

the stables and ammonia vapours enhance effect by

damage animal breathing system.

The cost for other treatments of the manure has high yearly

costs



Restraint



Solution

Stables are costly to build and run

Large alterations halts production of live stock



Provide the

Zitta®StableFlush

as add-on solutions to

existing stables reducing ammonia vapours and produce a

pure non-organic fertilizer as a commercial product, thus

generate income from the solution

Re-N expects the introduction of the new

Zitta®StableFlush

concept

to have a large impact on the Agricultural Production of live stock and

contribute to its survival

To ensure fast and broad establishment in the market, Re-N plans to

up-scale their production capacity and thus decrease the costs of the

Zitta®StableFlush

Strategy

MOF, Alm.del - 2016-17 - Bilag 141: Henvendelse af 1/12-16 fra RE-N Technology Group om MRSA-løsning for svinestalde

Financial Highlights

CAPEX:

Seperater / Decanter

Zitta

Fertilizer

Tanks, pumps, pipes etc

€ 300,000

OPEX:

MAINTENANCE 1% 3.000

ELECTRICITY

SCINOX / ACIDS

Financial costs

10% up-front payment - 4% rate for 20y annuity

€ 6,000

3,000

1,000

2,000

€ 32,968

Revenue

Sale of non organic ammonium sulphate

Annual cost

€ 3,600

€ 35,368

Cost per kg.

of produced piglet (100kg.)

€ 0.035



It is known from Dutch (Dr. Ir. A.J.A. (André) Aarnink et al.) studies that the quality improvement of piglet meat form better air, is worth

more than €

0.015

per kg.



We estimate costs to be EUR 0.02 per kg.



There are probably many other improvements for the production from improved air quality in the Pig sties